[Attempted marrow rescue with cryopreserved circulating stem cells following high-dose chemotherapy]. 1988

T Watanabe, and Y Takaue, and A H Mahbubul Huq, and T Koyama, and Y Kawano, and J Sato, and T Ninomiya, and M Hino, and H Takehara, and N Komi
Dept. of Pediatrics, University Hospital of Tokushima.

Circulating hematopoietic stem cells were collected by three consecutive leukaphereses during post-chemotherapy expansion of the stem cell pool in a 3-year-old boy with advanced and therapy-resistant neuroblastoma. The cells were fractionated by discontinuous Percoll gradient centrifugation, frozen in a programmed freezer and then stored in liquid nitrogen. Following high-dose chemotherapy, the cells were thawed rapidly and re-infused into the patient. Early evidence of marrow recovery was first noted at day 13 and the times required to achieve a granulocyte count of greater than 0.5 x 10(9)/L and a platelet count of greater than 50 x 10(9)/L were 21 days and 30 days, respectively. This new marrow-rescue operation may have potential in cancer therapy as an alternative to bone marrow transplantation and further clinical investigation is warranted.

UI MeSH Term Description Entries
D007937 Leukapheresis The preparation of leukocyte concentrates with the return of red cells and leukocyte-poor plasma to the donor. Leukocytapheresis,Leukopheresis,Lymphapheresis,Lymphocytapheresis,Leukocytopheresis,Lymphocytopheresis,Lymphopheresis,Leukaphereses,Leukocytaphereses,Leukocytophereses,Leukophereses,Lymphaphereses,Lymphocytaphereses,Lymphocytophereses,Lymphophereses
D008297 Male Males
D008558 Melphalan An alkylating nitrogen mustard that is used as an antineoplastic in the form of the levo isomer - MELPHALAN, the racemic mixture - MERPHALAN, and the dextro isomer - MEDPHALAN; toxic to bone marrow, but little vesicant action; potential carcinogen. Medphalan,Merphalan,Phenylalanine Mustard,Sarcolysine,Sarkolysin,4-(Bis(2-chloroethyl)amino)phenylalanine,Alkeran,L-PAM,Mustard, Phenylalanine
D009447 Neuroblastoma A common neoplasm of early childhood arising from neural crest cells in the sympathetic nervous system, and characterized by diverse clinical behavior, ranging from spontaneous remission to rapid metastatic progression and death. This tumor is the most common intraabdominal malignancy of childhood, but it may also arise from thorax, neck, or rarely occur in the central nervous system. Histologic features include uniform round cells with hyperchromatic nuclei arranged in nests and separated by fibrovascular septa. Neuroblastomas may be associated with the opsoclonus-myoclonus syndrome. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2099-2101; Curr Opin Oncol 1998 Jan;10(1):43-51) Neuroblastomas
D011034 Podophyllotoxin A lignan (LIGNANS) found in PODOPHYLLIN resin from the roots of PODOPHYLLUM plants. It is a potent spindle poison, toxic if taken internally, and has been used as a cathartic. It is very irritating to skin and mucous membranes, has keratolytic actions, has been used to treat warts and keratoses, and may have antineoplastic properties, as do some of its congeners and derivatives. Epipodophyllotoxin,CPH86,Condyline,Condylox,Podocon-25,Podofilm,Podofilox,Podophyllotoxin, (5R-(5 alpha,5a alpha,8a alpha,9 alpha))-Isomer,Podophyllotoxin, (5R-(5 alpha,5a alpha,8a alpha,9 beta))-Isomer,Podophyllotoxin, (5R-(5 alpha,5a alpha,8a beta,9 alpha))-Isomer,Podophyllotoxin, (5R-(5 alpha,5a beta,8a alpha,9 beta))-Isomer,Wartec,Warticon
D001793 Blood Preservation The process by which blood or its components are kept viable outside of the organism from which they are derived (i.e., kept from decay by means of a chemical agent, cooling, or a fluid substitute that mimics the natural state within the organism). Blood Preservations,Preservation, Blood,Preservations, Blood
D001859 Bone Neoplasms Tumors or cancer located in bone tissue or specific BONES. Bone Cancer,Cancer of Bone,Cancer of the Bone,Neoplasms, Bone,Bone Neoplasm,Neoplasm, Bone
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D002945 Cisplatin An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle. Platinum Diamminodichloride,cis-Diamminedichloroplatinum(II),cis-Dichlorodiammineplatinum(II),Biocisplatinum,Dichlorodiammineplatinum,NSC-119875,Platidiam,Platino,Platinol,cis-Diamminedichloroplatinum,cis-Platinum,Diamminodichloride, Platinum,cis Diamminedichloroplatinum,cis Platinum
D005615 Freezing Liquids transforming into solids by the removal of heat. Melting

Related Publications

T Watanabe, and Y Takaue, and A H Mahbubul Huq, and T Koyama, and Y Kawano, and J Sato, and T Ninomiya, and M Hino, and H Takehara, and N Komi
January 1991, Bone marrow transplantation,
T Watanabe, and Y Takaue, and A H Mahbubul Huq, and T Koyama, and Y Kawano, and J Sato, and T Ninomiya, and M Hino, and H Takehara, and N Komi
March 1977, European journal of cancer,
T Watanabe, and Y Takaue, and A H Mahbubul Huq, and T Koyama, and Y Kawano, and J Sato, and T Ninomiya, and M Hino, and H Takehara, and N Komi
March 1996, Lancet (London, England),
T Watanabe, and Y Takaue, and A H Mahbubul Huq, and T Koyama, and Y Kawano, and J Sato, and T Ninomiya, and M Hino, and H Takehara, and N Komi
January 1996, British journal of hospital medicine,
T Watanabe, and Y Takaue, and A H Mahbubul Huq, and T Koyama, and Y Kawano, and J Sato, and T Ninomiya, and M Hino, and H Takehara, and N Komi
January 1980, Cancer treatment reports,
T Watanabe, and Y Takaue, and A H Mahbubul Huq, and T Koyama, and Y Kawano, and J Sato, and T Ninomiya, and M Hino, and H Takehara, and N Komi
April 2010, Pediatric blood & cancer,
T Watanabe, and Y Takaue, and A H Mahbubul Huq, and T Koyama, and Y Kawano, and J Sato, and T Ninomiya, and M Hino, and H Takehara, and N Komi
January 2001, Cancer investigation,
T Watanabe, and Y Takaue, and A H Mahbubul Huq, and T Koyama, and Y Kawano, and J Sato, and T Ninomiya, and M Hino, and H Takehara, and N Komi
July 2000, Bone marrow transplantation,
T Watanabe, and Y Takaue, and A H Mahbubul Huq, and T Koyama, and Y Kawano, and J Sato, and T Ninomiya, and M Hino, and H Takehara, and N Komi
May 2003, The New England journal of medicine,
T Watanabe, and Y Takaue, and A H Mahbubul Huq, and T Koyama, and Y Kawano, and J Sato, and T Ninomiya, and M Hino, and H Takehara, and N Komi
January 1996, Breast cancer research and treatment,
Copied contents to your clipboard!